An integrative study of CTC transcriptomes presented us with the opportunity to discover consistent pan-cancer CTC surface-proteins, besides EpCAM. We looked for surface-protein coding genes that are deferentially upregulated in CTCs over blood cells (Supplementary Note-3). The gene discussed is EPCAM; the disease is cancer.